This resolution expresses support for (1) the goals and ideals of American Diabetes Month, including encouraging individuals to fight diabetes through public awareness about prevention and treatment options and enhancing education about the disease; and (2) decreasing the prevalence of type 1, type 2, and gestational diabetes in the United States through increased research, treatment, and prevention.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1237 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. RES. 1237
Supporting the goals and ideals of American Diabetes Month.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 24, 2020
Ms. DeGette (for herself, Mr. Reed, Mr. Ruiz, Mr. Kelly of
Pennsylvania, Ms. DelBene, and Mrs. Brooks of Indiana) submitted the
following resolution; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
RESOLUTION
Supporting the goals and ideals of American Diabetes Month.
Whereas, according to the Centers for Disease Control and Prevention (referred
to in this preamble as the ``CDC'')--
(1) 34,200,000 individuals in the United States have diabetes; and
(2) an estimated 88,000,000 individuals in the United States who are 18
years of age or older have prediabetes;
Whereas diabetes is a serious chronic condition that affects individuals of
every age, race, ethnicity, and income level;
Whereas the CDC reports that--
(1) Hispanic Americans, African Americans, Asian Americans, and Native
Americans are disproportionately affected by diabetes and develop the
disease at much higher rates than the general population of the United
States; and
(2) an estimated 21.4 percent of individuals with diabetes in the
United States have not yet been diagnosed with the disease;
Whereas, in the United States, more than 10.5 percent of the population,
including 26.8 percent of individuals who are 65 years of age or older,
have diabetes;
Whereas, of the 17,400,000 veterans in the United States, 8,800,000 who are 65
years of age or older, and 1 in 4 overall, are receiving care for
diabetes from the Department of Veterans Affairs;
Whereas the risk of developing diabetes at some point in life is 40 percent for
adults in the United States;
Whereas, according to the American Diabetes Association, the United States spent
an estimated $237,000,000,000 on direct medical costs for cases of
diagnosed diabetes in 2017, and out-of-pocket costs for insulin have
grown significantly in recent years for many patients;
Whereas the American Diabetes Association reports that care for people with
diagnosed diabetes accounts for 1 in 4 health care dollars spent in the
United States;
Whereas the cost of health care is estimated to be 2.3 times higher for
individuals in the United States with diabetes than those without
diabetes;
Whereas, as of November 2020, a cure for diabetes does not exist;
Whereas there are successful means to reduce the incidence, and delay the onset,
of type 2 diabetes;
Whereas, with proper management and treatment, individuals with diabetes live
healthy and productive lives; and
Whereas individuals in the United States celebrate American Diabetes Month in
November: Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the goals and ideals of American Diabetes
Month, including--
(A) encouraging individuals in the United States to
fight diabetes through public awareness of prevention
and treatment options; and
(B) enhancing diabetes education;
(2) recognizes the importance of awareness and early
detection, including awareness of symptoms and risk factors
such as--
(A) being--
(i) older than 45 years of age; or
(ii) overweight; and
(B) having--
(i) a particular racial and ethnic
background;
(ii) a low level of physical activity;
(iii) high blood pressure;
(iv) a family history of diabetes; or
(v) a history of diabetes during pregnancy;
(3) supports decreasing the prevalence of type 1, type 2,
and gestational diabetes in the United States through research,
treatment, and prevention; and
(4) recognizes the importance of addressing systemic
barriers to health care that--
(A) leave many vulnerable communities at a
heightened risk for diabetes; and
(B) limit access to health care resources that are
needed to effectively prevent the onset, and to manage
the condition, of diabetes.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line